EUDA Health Holdings Ltd EUDA.OQ EUDA.O is expected to report resultson May 6 (estimated) for the period ending March 31 2024
The Singapore-based company is expected to report revenue of $1.34 million, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for EUDA Health Holdings Ltd is for a loss of 2 cents per share.
The one available analyst rating on the shares is "buy".
The average consensus recommendation for the advanced medical equipment & technology peer group is also "Buy".
Wall Street's median 12-month price target for EUDA Health Holdings Ltd is $6.00, above its last closing price of $3.69.
This summary was machine generated May 2 at 11:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)